Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Chinese Patients with Rheumatoid Arthritis
NCT00538902Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Aug 2007
- Primary completion
- Jul 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of adalimumab in rheumatoid arthritis (RA), sponsored by Abbott Laboratories. Started Aug 2007; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00538902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00538902.